Strategic Decision Making in the Life Sciences Industry: Managing the Build vs. Buy Dilemma
In the competitive landscape of the life sciences industry, strategic decision-making is paramount. Among these decisions, the choice between internal development and manufacturing ('build') versus partnering with Contract Development and Manufacturing Organizations (CDMOs) ('buy') is crucial. This decision can significantly influence a company's path towards innovation, efficiency, and market success, especially in an era where...

